Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Circulating long non-coding RNAs in plasma of patients with gastric cancer.

Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, Fujiwara H, Okamoto K, Otsuji E.

Anticancer Res. 2013 Aug;33(8):3185-93.

PMID:
23898077
2.

Long non-coding RNAs: a new frontier in the study of human diseases.

Shi X, Sun M, Liu H, Yao Y, Song Y.

Cancer Lett. 2013 Oct 10;339(2):159-66. doi: 10.1016/j.canlet.2013.06.013. Epub 2013 Jun 18. Review.

PMID:
23791884
3.

Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.

Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J, Sun Y.

Eur J Cancer. 2013 Sep;49(13):2949-59. doi: 10.1016/j.ejca.2013.04.026. Epub 2013 May 28.

PMID:
23726266
4.

Long non-coding RNA expression profile in human gastric cancer and its clinical significances.

Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, Xia T, Xiao B, Xi Y, Guo J.

J Transl Med. 2013 Sep 24;11:225. doi: 10.1186/1479-5876-11-225.

5.

Targeting long non-coding RNAs in cancers: progress and prospects.

Li CH, Chen Y.

Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910. doi: 10.1016/j.biocel.2013.05.030. Epub 2013 Jun 4. Review.

PMID:
23748105
6.

Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.

Zhou X, Yin C, Dang Y, Ye F, Zhang G.

Sci Rep. 2015 Jun 22;5:11516. doi: 10.1038/srep11516.

7.

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.

Ke D, Li H, Zhang Y, An Y, Fu H, Fang X, Zheng X.

Oncotarget. 2017 Mar 28;8(13):21516-21525. doi: 10.18632/oncotarget.15628.

8.

Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.

Hashad D, Elbanna A, Ibrahim A, Khedr G.

J Clin Lab Anal. 2016 Nov;30(6):1100-1105. doi: 10.1002/jcla.21987. Epub 2016 May 17.

PMID:
27184562
9.

Circulating microRNAs in plasma of patients with gastric cancers.

Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2010 Mar 30;102(7):1174-9. doi: 10.1038/sj.bjc.6605608. Epub 2010 Mar 16.

10.

Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Huang YK, Yu JC.

World J Gastroenterol. 2015 Sep 14;21(34):9863-86. doi: 10.3748/wjg.v21.i34.9863. Review.

11.

Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.

Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G.

FEBS J. 2012 Sep;279(17):3159-65. doi: 10.1111/j.1742-4658.2012.08694.x. Epub 2012 Jul 31.

12.

Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer.

Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, Wang B, Ye G, Xiao B, Guo J.

Tumour Biol. 2015 Mar;36(3):2007-12. doi: 10.1007/s13277-014-2807-y. Epub 2014 Nov 13.

PMID:
25391424
13.

Molecular mechanisms of long noncoding RNAs on gastric cancer.

Li T, Mo X, Fu L, Xiao B, Guo J.

Oncotarget. 2016 Feb 23;7(8):8601-12. doi: 10.18632/oncotarget.6926. Review.

14.

Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls.

Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu QH, Weng WW, Tan C, Sheng WQ, Zhou XY, Du X.

Int J Cancer. 2015 Sep 1;137(5):1128-35. doi: 10.1002/ijc.29484. Epub 2015 Mar 9.

15.

Integrated analysis of long non-coding RNAs and mRNA expression profiles reveals the potential role of lncRNAs in gastric cancer pathogenesis.

Lin XC, Zhu Y, Chen WB, Lin LW, Chen DH, Huang JR, Pan K, Lin Y, Wu BT, Dai Y, Tu ZG.

Int J Oncol. 2014 Aug;45(2):619-28. doi: 10.3892/ijo.2014.2431. Epub 2014 May 9.

PMID:
24819045
16.

Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.

Gao J, Cao R, Mu H.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12936-42. eCollection 2015.

17.

Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.

Tani N, Ichikawa D, Ikoma D, Tomita H, Sai S, Ikoma H, Okamoto K, Ochiai T, Ueda Y, Otsuji E, Yamagishi H, Miura N, Shiota G.

Anticancer Res. 2007 Mar-Apr;27(2):1207-12.

18.

Long noncoding RNAs: novel insights into gastric cancer.

Fang XY, Pan HF, Leng RX, Ye DQ.

Cancer Lett. 2015 Jan 28;356(2 Pt B):357-66. doi: 10.1016/j.canlet.2014.11.005. Epub 2014 Nov 7. Review.

PMID:
25444905
19.

Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.

Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.

Hepatogastroenterology. 2008 May-Jun;55(84):1131-5.

PMID:
18705345
20.

Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development.

Park JY, Lee JE, Park JB, Yoo H, Lee SH, Kim JH.

Brain Tumor Res Treat. 2014 Apr;2(1):1-6. doi: 10.14791/btrt.2014.2.1.1. Epub 2014 Apr 29. Review.

Supplemental Content

Support Center